Actionable news
0
All posts from Actionable news
Actionable news in BMY: BRISTOL-MYERS SQUIBB CO.,

FDA expands use of Bristol Myers' cancer drug Yervoy

The U.S. Food and Drug Administration expanded the use of Bristol-Myers Squibb Co's skin cancer drug, Yervoy, as an additional therapy for patients with late-stage melanoma.

This approval extends Yervoy's use to patients with stage III melanoma, who have a high risk of recurrence after surgery, the agency said on Wednesday.

Due to the potential for fatal adverse reactions and unusual severe side effects with Yervoy, the drug's label carries a boxed...


More